Sector: Industrials
Director information for TRANSCAT INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Christopher P. Gillette | Retired Lean Leader Sales & Marketing of GE Aviation; Director | 65 | ["Extensive leadership and calibration industry experience","Considerable experience with client relations, sales and marketing","Strategic planning and market development experience"] | ["CC","NESGC","TC","Compensation","NESG","Technology"] | 2026 |
| Craig D. Cairns | President of Howe & Rusling, Inc. | 61 | ["more than 25 years of investment experience","extensive leadership experience","considerable experience with client relations","capital allocation","sales and marketing","strategic planning and execution"] | ["CC","Compensation"] | 2026 |
| Cynthia M. Langston | Senior Vice President and Chief Information Officer | 65 | ["extensive experience in enterprise strategy","information technology","cybersecurity","analytics","operational, technology and risk management expertise","deep management and leadership experience"] | ["Audit","Technology"] | 2026 |
| Dawn G. DePerrior | Retired Managing Director in EY’s Healthcare Technology Consulting Practice | 68 | ["Retired managing director at Ernst & Young’s healthcare technology consulting practice","40 years of experience in Information Technology (IT)","Expertise in strategy, business transformation, cyber security, digitization, data, analytics, innovation, mergers and acquisition integration, and finance","Led business information technology transformation teams at Constellation Brands and the University of Rochester Medical Center","Former board chair for the Villa of Hope","Member of the board of directors for North Coast Holdings and Highland Hospital in Rochester, New York","Served on the board of directors of Evans Bancorp Inc."] | ["CC","NESGC","TC","Compensation","NESG","Technology"] | 2026 |
| Gary J. Haseley | Chairman of Board of the Company; Retired Senior Vice President and General Manager of Kaman Automation, Control & Energy; Chairman of the Board | 64 | ["Chairman of the Board since September 2020","Senior Vice President and General Manager of Kaman Automation, Control & Energy until November 2016","President and Chief Executive Officer of Zeller Corporation from January 2001 to August 2012","Vice President of Sales at Zeller Corporation from 1995 until 2001","Board member of Jerash Holdings (US), Inc. (Nasdaq: JRSH) from May 2018 until December 2019","Experience in distribution and services markets"] | ["EC","Executive"] | 2026 |
| Jaime A. Irick | President and Chief Executive Officer of the Company | 52 | ["Accomplished business-to-business executive","Leading large-scale industrial and technology enterprises","Driving profitable growth through digital and business model optimizations","Operational excellence and authentic leadership","Experience as a public company director"] | ["EC","Executive"] | 2026 |
| Mbago M. Kaniki | Chief Executive Officer of Adansonia Management LLC | 48 | ["Chief Executive Officer of Adansonia Management LLC since March 2013","Chief Executive Officer of Alva Charge LLC from May 2016 to April 2021","Experience with complex transactions including debt and equity financings and mergers and acquisitions","Leadership experience in driving business growth and transformation"] | ["NESGC","AC","EC","NESG","Audit","Executive"] | 2026 |
| Oksana S. Dominach | Senior Vice President, Beer Finance of Constellation Brands, Inc. | 62 | ["more than 35 years of experience and expertise in financial strategy and risk management","over ten years of experience participating on public and not-for-profit boards","capital structure management expertise","risk management expertise","corporate compliance expertise"] | ["AC","CC","EC","Audit (Chair)","Compensation","Executive"] | 2026 |
| Robert L. Mecca | Senior Vice President of Finance | 55 | ["More than two decades of US and international life science industry experience","Experience in both biotech and large pharma","More than 25 years of financial experience in the life sciences industry","Expertise in financial management, strategy development, business expansion and M&A","Led organizations through stages of growth and transformation"] | ["Audit"] | 2026 |
